IMRIS (IMRS.Q) Stock Analysis & Winston Score
IMRIS Inc. is a medical technology company that builds specialized operating rooms where surgeons can perform procedures while using MRI scanners at the same time. Its main product is the VISIUS Surgical Theatre, a system that combines surgical equipment with imaging technology so doctors can see inside a patient's body in real time during an operation. The company sells to hospitals and medical centers, primarily in North America and Europe. IMRIS makes money by selling these integrated surgical suite systems and through service contracts for maintenance and support. Each installation is a large, custom project worth millions of dollars, which means revenue can be lumpy and unpredictable from year to year. The company faced serious financial difficulties and filed for bankruptcy protection, reflected in the ".Q" suffix on its ticker, making its ability to continue operating and fund new installations the central risk for the business going forward.
Winston Score: 0/100 — Insufficient Data
Not enough data to score this stock reliably.
- Quality: Data not available (0/30)
- Growth: Data not available (0/20)
- Cash Flow: Data not available (0/10)
- Stability: Data not available (0/10)
- Valuation: Data not available (0/10)
- Ownership: Ownership data not available (not counted) (0/15)
